In-person event 8-11th April
Virginijus Šikšnys
Vilnius University Life Sciences Centre, Lithuania
Jimi Olaghere
Alessia Cavazza
University College London, United Kingdom
Alessio Strano
ETH Zürich, Switzerland
Alvin Luk
HuidaGene Therapeutics
Annarita Miccio
Imagine Institut, INSERM UMR1163, Paris Cite' University, France
Ayal Hendel
Bar-Ilan University, Israel
Antoine Decrulle
Eligo Bioscience, France
Cecilia Jimenez-Mallebrera
Institut de Recerca Sant Joan de Déu. Hospital Sant Joan de Déu Barcelona and CIBERER
Dana Carroll
University of Utah School of Medicine, United States
Daniel Siegwart
University of Texas Southwestern Medical Center, United States
Eric B. Kmiec
Gene Editing Institute, Christianacare; CorriXR Therapeutics, Inc., United States
Gerald Schwank
University of Zurich, Switzerland
Grégoire Cullot
ETH Zurich, Switzerland
Guillermo Montoya
University of Copenhagen, Denmark
Jacob Giehm Mikkelsen
Aarhus University, Denmark
Jakob Nilsson
Danish Cancer Institute, Copenhagen, Denmark
James Longden
Evolvus, United Kingdom
Julian Grünewald
Technical University of Munich, Germany
Karim Benabdel Lah El Khlanji
GENyO Pfizer-University of Granada-Junta de Andalucia Center for Genomics and Oncological Research in Granada, Spain
Kiana Aran
University of California San Diego, United States
Lilian Tawsy Lamech
Life Edit Therapeutics, an ElevateBio Company, United States
Marcello Maresca
AstraZeneca, Sweden
Martin Pacesa
EPFL, Lausanne, Switzerland
Matthew Porteus
Stanford University, United States
Özcan Met
Cell Therapy Unit CCIT-DK and DTU HealthTech, Denmark
Raffaella Di Micco
SR-TIGET, Milan and IUSS, Pavia, Italy
Rasmus O. Bak
Aarhus University, Denmark
Rob Wolthuis
Amsterdam UMC, Netherlands
Srinivasan Chandrasegaran
Johns Hopkins School of Public Health, United States
Thorsten Stafforst
University of Tuebingen, Germany
Traver Hart
MD Anderson Cancer Center, United States
Amanda Haas
Agilent Technologies
Ashley Jacobi
Integrated DNA Technologies, United States
Iván Hernández-Neuta
Countagen, Sweden
Juliana Campo
GenScript Biotech (Netherlands) B.V.
Max Sellman
Aldevron
Philipp Kamm
Project Lead | Specialist Enzymatic Nucleic Acid Synthesis, BioSpring
Simon Reed
Broken String Biosciences, United Kingdom
Manuel Kaulich
Vivlion GmbH and Goethe University Frankfurt
Giedrius Gasiunas
Caszyme, Lithuania